Chemed Corp. (NYSE:CHE) is set to announce its earnings results after the market closes on Thursday, October 26th. Analysts expect the company to announce earnings of $2.00 per share for the quarter. Chemed Corp. has set its FY17 guidance at $8.10-8.20 EPS.
Chemed Corp. (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The business had revenue of $415.06 million during the quarter, compared to analysts’ expectations of $407.56 million. During the same period in the previous year, the business posted $1.80 EPS. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, analysts expect Chemed Corp. to post $8.21 EPS for the current fiscal year and $8.84 EPS for the next fiscal year.
Shares of Chemed Corp. (NYSE:CHE) opened at 205.54 on Thursday. The firm’s 50-day moving average is $197.51 and its 200 day moving average is $198.35. Chemed Corp. has a 52 week low of $132.92 and a 52 week high of $216.01. The firm has a market capitalization of $3.29 billion, a PE ratio of 50.99 and a beta of 1.13.
In related news, insider Kevin J. Mcnamara sold 15,000 shares of the stock in a transaction on Friday, July 28th. The stock was sold at an average price of $201.16, for a total transaction of $3,017,400.00. Following the completion of the sale, the insider now directly owns 173,801 shares of the company’s stock, valued at $34,961,809.16. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Patrick P. Grace sold 500 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $201.48, for a total value of $100,740.00. Following the sale, the director now directly owns 4,515 shares of the company’s stock, valued at $909,682.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 16,500 shares of company stock valued at $3,315,600. Corporate insiders own 4.90% of the company’s stock.
CHE has been the topic of a number of research reports. BidaskClub lowered shares of Chemed Corp. from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 22nd. Zacks Investment Research upgraded shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $213.00 target price on the stock in a research report on Wednesday, August 23rd. TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Finally, Royal Bank Of Canada restated a “hold” rating and set a $209.00 target price on shares of Chemed Corp. in a research report on Friday, September 1st. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $215.00.
ILLEGAL ACTIVITY WARNING: “Chemed Corp. (CHE) Set to Announce Quarterly Earnings on Thursday” was first published by Week Herald and is the property of of Week Herald. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://weekherald.com/2017/10/19/chemed-corp-che-set-to-announce-quarterly-earnings-on-thursday.html.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.